Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-25-010829
Filing Date
2025-08-08
Accepted
2025-08-07 20:24:04
Documents
81
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ntra-20250630x10q.htm   iXBRL 10-Q 2144219
2 EX-10.1 ntra-20250630xex10d1.htm EX-10.1 20126
3 EX-31.1 ntra-20250630xex31d1.htm EX-31.1 13730
4 EX-31.2 ntra-20250630xex31d2.htm EX-31.2 14792
5 EX-32.1 ntra-20250630xex32d1.htm EX-32.1 10276
6 EX-32.2 ntra-20250630xex32d2.htm EX-32.2 10555
  Complete submission text file 0001558370-25-010829.txt   9484391

Data Files

Seq Description Document Type Size
7 EX-101.SCH ntra-20250630.xsd EX-101.SCH 59599
8 EX-101.CAL ntra-20250630_cal.xml EX-101.CAL 57341
9 EX-101.DEF ntra-20250630_def.xml EX-101.DEF 241573
10 EX-101.LAB ntra-20250630_lab.xml EX-101.LAB 510553
11 EX-101.PRE ntra-20250630_pre.xml EX-101.PRE 387226
84 EXTRACTED XBRL INSTANCE DOCUMENT ntra-20250630x10q_htm.xml XML 1892072
Mailing Address 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753
Business Address 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753 650-249-9090
Natera, Inc. (Filer) CIK: 0001604821 (see all company filings)

EIN.: 010894487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37478 | Film No.: 251195917
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)